Kim Yoon Sik, Kim Young-Beom, Kim Woong Bin, Lee Seung Won, Oh Seog Bae, Han Hee-Chul, Lee C Justin, Colwell Christopher S, Kim Yang In
Department of Physiology and Neuroscience Research Institute, Korea University College of Medicine, 126-1 Anam-dong 5-ga, Seoul, 136-705, Republic of Korea.
Department of Psychiatry & Biobehavioral Sciences, University of California-Los Angeles, 760 Westwood Plaza, Los Angeles, CA, 90024, USA.
Mol Brain. 2016 May 6;9(1):49. doi: 10.1186/s13041-016-0227-1.
Recent evidence indicates that histamine, acting on histamine 1 receptor (H1R), resets the circadian clock in the mouse suprachiasmatic nucleus (SCN) by increasing intracellular Ca(2+) concentration ([Ca(2+)]i) through the activation of CaV1.3 L-type Ca(2+) channels and Ca(2+)-induced Ca(2+) release from ryanodine receptor-mediated internal stores.
In the current study, we explored the underlying mechanisms with various techniques including Ca(2+)- and Cl(-)-imaging and extracellular single-unit recording. Our hypothesis was that histamine causes Cl(-) efflux through cystic fibrosis transmembrane conductance regulator (CFTR) to elicit membrane depolarization needed for the activation of CaV1.3 Ca(2+) channels in SCN neurons. We found that histamine elicited Cl(-) efflux and increased [Ca(2+)]i in dissociated mouse SCN cells. Both of these events were suppressed by bumetanide [Na(+)-K(+)-2Cl(-) cotransporter isotype 1 (NKCC1) blocker], CFTRinh-172 (CFTR inhibitor), gallein (Gβγ protein inhibitor) and H89 [protein kinase A (PKA) inhibitor]. By itself, H1R activation with 2-pyridylethylamine increased the level of cAMP in the SCN and this regulation was prevented by gallein. Finally, histamine-evoked phase shifts of the circadian neural activity rhythm in the mouse SCN slice were blocked by bumetanide, CFTRinh-172, gallein or H89 and were not observed in NKCC1 or CFTR KO mice.
Taken together, these results indicate that histamine recruits the H1R-Gβγ-cAMP/PKA pathway in the SCN neurons to activate CaV1.3 channels through CFTR-mediated Cl(-) efflux and ultimately to phase-shift the circadian clock. This pathway and NKCC1 may well be potential targets for agents designed to treat problems resulting from the disturbance of the circadian system.
最近的证据表明,组胺作用于组胺1受体(H1R),通过激活CaV1.3 L型钙通道增加细胞内钙离子浓度([Ca(2+)]i),并从兰尼碱受体介导的内部储存中诱导钙离子释放,从而重置小鼠视交叉上核(SCN)的生物钟。
在本研究中,我们使用包括钙离子和氯离子成像以及细胞外单单位记录等多种技术探索了其潜在机制。我们的假设是,组胺通过囊性纤维化跨膜传导调节因子(CFTR)引起氯离子外流,以引发SCN神经元中激活CaV1.3钙通道所需的膜去极化。我们发现组胺在解离的小鼠SCN细胞中引起氯离子外流并增加[Ca(2+)]i。这两个事件均被布美他尼[钠钾氯共转运体1型(NKCC1)阻滞剂]、CFTRinh-172(CFTR抑制剂)、加列因(Gβγ蛋白抑制剂)和H89[蛋白激酶A(PKA)抑制剂]所抑制。单独使用2-吡啶乙胺激活H1R可增加SCN中的cAMP水平,而加列因可阻止这种调节。最后,布美他尼、CFTRinh-172、加列因或H89可阻断组胺引起的小鼠SCN切片中昼夜神经活动节律的相位偏移,而在NKCC1或CFTR基因敲除小鼠中未观察到这种相位偏移。
综上所述,这些结果表明,组胺在SCN神经元中募集H1R-Gβγ-cAMP/PKA途径,通过CFTR介导的氯离子外流激活CaV1.3通道,最终使生物钟发生相位偏移。该途径和NKCC1很可能是旨在治疗昼夜节律系统紊乱所致问题的药物的潜在靶点。